Christina Economides, MD, MM, FSCAI* Director, STEMI Receiving Center Director, Women's Cardiovascular Health Program Associate Program Director, Harbor UCLA Medical Center/PIH Health Good Samaritan Hospital Interventional Cardiology Fellowship Program PIH Health Good Samaritan HospitalLos Angeles, CA
Steven Burstein, MD, FACC* Director, Interventional Cardiology Director, Structural Heart Program PIH Health Good Samaritan Hospital Los Angeles, CA
Uri Elkayam, MD, FACC Professor of Medicine, Division of Cardiology University of Southern California Keck School of Medicine Los Angeles, CA
Michelle Kittleson, MD, PhD Director, Post-Graduate Education in Heart Failure and Transplantation Professor of Medicine Smidt Heart Institute, Cedars-Sinai Los Angeles, CA
Nichelle Megowan, MD Interventional Cardiologist Harbor UCLA Medical Center Torrance, CA
Ronald Oudiz, MD, FACC, FCCP Professor of Medicine, David Geffen School of Medicine at UCLA Chief, Division of Cardiology Director, Liu Center for Pulmonary Hypertension Harbor-UCLA Medical Center Torrance, CA
Joseph Rahman, MD* Director, Heart Failure Program PIH Health Good Samaritan Hospital Los Angeles, CA
Ravi Sureddi, MD* Co-Director, Cardiac Electrophysiology PIH Health Good Samaritan Hospital Los Angeles, CA
Karol Watson, MD, PhD, FACC Professor of Medicine/Cardiology Co-director, UCLA Program in Preventive Cardiology Director, UCLA Barbra Streisand Women's Heart Health Program David Geffen School of Medicine at UCLA Los Angeles, CA John Mazziotta, MD, PhD Term Chair in Medicine Los Angeles, CA
Janet Wei, MD, FACC Erika J. Glazer Chair in Women’s Cardiovascular Research, Education and Innovation Associate Professor of Cardiology and Biomedical Sciences Barbra Streisand Women’s Heart Center, Cedars-Sinai Smidt Heart Institute Cedars-Sinai Medical Center Los Angeles, CA
Katrine Zhiroff, MD, FACC, FSCAI* Section Lead, PIH Health Physicians Cardiology Services PIH Health Downey Hospital Downey, CA
*Los Angeles Cardiology Associates
It is our policy to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.